Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Nuvation Bio (NUVB-WT) Non Operating Income (2023 - 2025)

Nuvation Bio (NUVB-WT) has disclosed Non Operating Income for 3 consecutive years, with -$8.7 million as the latest value for Q4 2025.

  • Quarterly Non Operating Income rose 56.94% to -$8.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $2.3 million through Dec 2025, up 2165.14% year-over-year, with the annual reading at $2.3 million for FY2025, 2165.14% up from the prior year.
  • Non Operating Income for Q4 2025 was -$8.7 million at Nuvation Bio, down from $642000.0 in the prior quarter.
  • The five-year high for Non Operating Income was $7.9 million in Q2 2024, with the low at -$20.3 million in Q4 2024.
  • Average Non Operating Income over 3 years is $2.2 million, with a median of $5.4 million recorded in 2023.
  • The sharpest move saw Non Operating Income tumbled 388.19% in 2024, then surged 56.94% in 2025.
  • Over 3 years, Non Operating Income stood at $7.0 million in 2023, then crashed by 388.19% to -$20.3 million in 2024, then soared by 56.94% to -$8.7 million in 2025.
  • According to Business Quant data, Non Operating Income over the past three periods came in at -$8.7 million, $642000.0, and $4.6 million for Q4 2025, Q3 2025, and Q2 2025 respectively.